Advertisements


We are Sorry, This Page doesn't Exist


First Week of August 16th Options Trading For Tetraphase Pharmaceuticals (TTPH)

Stock Options Channel.....»»

Category: topSource: redinewsJan 4th, 2019

The top 26 largest company IPOs of the year

More than half of companies that have gone public this year are in pharmaceuticals and life sciences or technology, media and telecommu.....»»

Category: topSource: usatodayDec 7th, 2018

Tetraphase Pharmaceuticals" (TTPH) CEO Guy MacDonald on Q3 2018 Results - Earnings Call Transcript

Tetraphase Pharmaceuticals" (TTPH) CEO Guy MacDonald on Q3 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaNov 8th, 2018

Tetraphase Prepares for US Launch of Xerava

Tetraphase Pharmaceuticals shares were up handily on Friday after the company announced the U.S. commercial launch of Xerava (eravacycline) for the treatment of complicated intra-abdominal infections......»»

Category: blogSource: 247wallstOct 12th, 2018

Tetraphase Prepares for US Launch of Xevara

Tetraphase Pharmaceuticals shares were up handily on Friday after the company announced the U.S. commercial launch of Xerava (eravacycline) for the treatment of complicated intra-abdominal infections......»»

Category: blogSource: 247wallstOct 12th, 2018

CASI Pharmaceuticals Announces Second Quarter And First Half 2018 Financial And Business Results

CASI Pharmaceuticals Announces Second Quarter And First Half 2018 Financial And Business Results - China FDA (CFDA) import drug re.....»»

Category: earningsSource: benzingaAug 14th, 2018

Here"s Why Aurinia Pharmaceuticals Inc. Gained 32.2% in the First Half of 2018

What happened Shares of Aurinia Pharmaceuticals Inc NASDAQ AUPH 160 a clinical stage biotechnology company gained 32 2 in the first half of 2018 according to data from S amp P Global Market Intelligence Investors anticipating success with the company s.....»»

Category: futuresSource: nasdaqJul 14th, 2018

Steven Cohen Keeps Buying Acadia Pharmaceuticals, a Stock Down by Half This Year

The FDA said it would re-examine the company's only drugCheck out Steven Cohen Stock Picks » Download GuruFolio Report of Steven Cohen (Updated on 06/19/2018)Related Stocks: ACAD,.....»»

Category: blogSource: gurufocusJun 20th, 2018

Drugmaker revives female libido pill at half the price

Sprout Pharmaceuticals Inc. is relaunching Addyi, the first-ever approved drug for low libido in women -- and it’s slashing the drug’s price in half......»»

Category: topSource: moneycentralJun 11th, 2018

Drugmaker revives female libido pill at half the price

Sprout Pharmaceuticals Inc. is relaunching Addyi, the first-ever approved drug for low libido in women -- and it’s slashing the drug’s price in half......»»

Category: topSource: moneycentralJun 11th, 2018

Tetraphase Pharmaceuticals, My Favorite 2H 2018 Biotech

Tetraphase Pharmaceuticals, My Favorite 2H 2018 Biotech.....»»

Category: topSource: seekingalphaMay 23rd, 2018

Tetraphase Pharmaceuticals (TTPH) Presents At H. C. Wainwright Global Life Sciences Conference - Slideshow

Tetraphase Pharmaceuticals (TTPH) Presents At H. C. Wainwright Global Life Sciences Conference - Slideshow.....»»

Category: topSource: seekingalphaApr 10th, 2018

Retailers Ross Stores, TJX Companies Expected To Lead Dividend Increases In Second Half Of February

Retailers Ross Stores, TJX Companies Expected To Lead Dividend Increases In Second Half Of February.....»»

Category: topSource: seekingalpha7 hr. 8 min. ago

6 ways top CEOs beat procrastination

Once begun, half done......»»

Category: topSource: moneycentral9 hr. 23 min. ago

SoftBank invests in Mubadala"s new $400 million European tech fund: source

Japan's SoftBank Group has provided nearly half of the cash for Abu Dhabi's state investor Mubadala Investment Co's new $400 million fund investing in European start-ups, a source familiar with the matter said......»»

Category: topSource: reuters17 hr. 53 min. ago

Crinetics Pharmaceuticals Seeks To Supplant Big Pharma Competition In Acromegaly

Crinetics Pharmaceuticals Seeks To Supplant Big Pharma Competition In Acromegaly.....»»

Category: topSource: seekingalpha19 hr. 53 min. ago

SoftBank invests in Mubadala"s new $400 million European tech fund: FT

Japan's SoftBank Group has provided nearly half the cash for the new $400 million fund by Abu Dhabi's state-owned Mubadala Investment Co that aims to back European start-ups, the Financial Times reported on Monday......»»

Category: topSource: reuters20 hr. 53 min. ago

The Data Behind Surging NBA Team Valuations

Submitted by Visual Capitalist At the beginning of this decade, the NBA was not on firm footing. More than half of the league.....»»

Category: blogSource: zerohedge21 hr. 23 min. ago

More Than Half Of Homes Listed In NYC Last Year Never Sold

A torrid post-cri.....»»

Category: blogSource: zerohedgeFeb 17th, 2019

Better Buy: Intercept Pharmaceuticals vs. Madrigal Pharmaceuticals

Which of these NASH stocks is the better pick right now?.....»»

Category: topSource: foxnewsFeb 17th, 2019